eWEEK content and product recommendations are editorially independent. We may make money when you click on links to our partners. Learn More.
Is all the RFID noise giving you a headache? Take two aspirin and call Accenture Ltd. in the morning.
The management consulting firm has organized a group of pharmaceutical manufacturers, distributors and retailers to explore radio frequency identifications (RFIDs) true ability to:
• enhance the safety and security of the pharmaceutical supply chain;
• improve the process of pharmaceutical returns management; and
* increase the efficiency of distribution operations.
Key project partners include Abbott Laboratories, Barr Pharmaceuticals, Cardinal Health, CVS Pharmacy, Johnson & Johnson, McKesson, Pfizer, Procter & Gamble, Rite Aid, Healthcare Distribution Management Association (HDMA) and National Association of Chain Drug Stores (NACDS). The group plans to test how RFID technology can improve:
• expiration date management;
• lot and batch tracking;
• returns management processing;
• shipping and receiving accuracy;
• operational integrity;
• and product security and consumer safety, among other areas.
Separately, Sun Microsystems Inc. and SupplyScape have launched an “anti-counterfeiting” RFID package that protects pharmaceuticals as they move through the supply chain.
These developments sound promising, but I suspect RFID is still 12 to 18 months away from wide scale deployment at most companies. (Read why in my recent RFID feature in eWeek).
For the full article click